Omeros Updates Phase 3 Zaltenibart PNH Clinical Trial
March 21, 2025
Phase 3 Data Needed for BLA Submission Expected in the Fourth Quarter 2026 Omeros Corporation reported that clinical trial site activation for enrollment is underway